Experimental immunotherapy zaps two most lethal Ebola virus strains

The first antibodies that can potently neutralize the two deadliest strains of the virus that causes Ebola hemorrhagic fever has been engineered by scientists. The findings, made in mice, are a significant step toward immunotherapies that are effective against all strains of Ebola virus that cause human disease.

Read the whole article on Science Daily

More from Science Daily